Randomised clinical trials: Linaclotide phase 3 studies in IBS-C - A prespecified further analysis based on European Medicines Agency-specified endpoints

E. M.M. Quigley, J. Tack, W. D. Chey, S. S. Rao, J. Fortea, M. Falques, C. Diaz, S. J. Shiff, M. G. Currie, J. M. Johnston

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Randomised clinical trials: Linaclotide phase 3 studies in IBS-C - A prespecified further analysis based on European Medicines Agency-specified endpoints'. Together they form a unique fingerprint.

Medicine & Life Sciences